8-K - Beyond Air, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events On January 13, 2026, Beyond Air, Inc. (“Beyond Air” or the “Company”) issued a press release announcing that XTL Biopharmaceuticals Ltd. (“XTL”) (N

Other Event

$1.0M$31.5M

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated January 13, 2026. 104 Cover Page Interactive Data File (embedd

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1